Science
Mechanism of Action
Osthole exerts its effects through multiple cellular pathways. It significantly reduces inflammation by inhibiting NF-κB activation, modulating the production of pro-inflammatory cytokines (IL-1β, TNF-α, CCL2/MCP-1, CCL5/RANTES) and chemokines (IL-8), and downregulating TLR2 and COX-2 expression. It also blocks MAPK/p38 pathways and inhibits 5-lipoxygenase. For barrier integrity and wound healing, Osthole enhances ZO-3 expression and stimulates keratinocyte proliferation and migration. Its antipruritic action stems from stabilizing mast cell membranes and inhibiting histamine release, while also blocking substance P signaling. Furthermore, Osthole contributes to anti-photoaging by decreasing oxidative stress, exhibits hygroscopic properties for moisturizing, and demonstrates broad-spectrum antibacterial and antifungal activity. In vitro studies indicate its capacity to inhibit melanin content and the activity of melanogenic enzymes such as tyrosinase, TRP-1, and TRP-2.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 In vitro analysis in B16F10 melanoma cells revealed that Osthole at a concentration of 4.9 μM effectively inhibited melanin content and the expression of key melanogenic enzymes, including tyrosinase, TRP-1, and TRP-2, suggesting a role in skin brightening.
- 02 In vitro assessments showed no observable cytotoxicity in LAD2 and RBL-2H3 mast cells when exposed to Osthole at concentrations ranging from approximately 200-400 μM, concentrations consistent with its ability to attenuate mast cell responses.
- 03 Treatment with 0.5 mg/mL Osthole significantly improved the structural integrity of normal human epithelial keratinocyte (NHEK) and normal human dermal fibroblast (NHDF) monolayers, as well as a 3D skin model, following inflammatory challenges with histamine or lipopolysaccharide (LPS), confirming its anti-inflammatory and barrier-protective properties.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Osthole is stable under recommended storage conditions. However, for maintaining maximum efficacy, aqueous solutions are not advised for storage exceeding one day. Optimal solubility in aqueous buffers is achieved by first dissolving Osthole in a solvent like dimethyl formamide (DMF) before dilution with the aqueous medium.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) and the Scientific Committee on Consumer Safety (SCCS) have not yet issued specific safety assessments for Osthole. Under U.S. law, cosmetic ingredients generally do not require pre-market FDA approval. While acute rodent toxicity studies for internal administration indicated an LD50 of approximately 710 mg/kg (intraperitoneal in mice) and subchronic oral administration in rats showed a NOAEL of less than 5 mg/kg/day with renal impairment at higher doses, these findings are for internal use and do not directly translate to topical cosmetic application. Notably, Osthole is included in 'The List of Used Cosmetic Ingredient' by the Ministry of Health of the People's Republic of China (2001) with no reported unsafety for external use.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Osthole is a valuable, multi-functional ingredient offering significant anti-inflammatory, barrier-supportive, and potential brightening benefits, suitable for all skin types with a generally low irritancy profile.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources